Insider Shareholders with Direct Ownership of Provention Bio, Inc. (PRVB)
This section provides a comprehensive overview of the insiders with direct ownership of Provention Bio, Inc. (PRVB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Provention Bio, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Francisco Leon
Chief Scientific Officer |
305,167 | 1,872,617 | 1,573,000 $0 | 17 |
Feb 13, 2023
Reduced 1.63%
|
Avery W Catlin
Director |
0 | 10,000 | 33,000 $0 | 1 |
May 17, 2022
Added 50.0%
|
Wayne Pisano
Director |
0 | 7,500 | 0 $0 | 1 |
Apr 27, 2023
Reduced 100.0%
|
Eleanor Ramos
Chief Medical Officer |
5,201 | 70,000 | 0 $0 | 2 |
Apr 27, 2023
Reduced 100.0%
|
Ashleigh Palmer
Director and CEO |
103,750 | 2,670,050 | 0 $0 | 8 |
Apr 27, 2023
Reduced 100.0%
|
Jason Hoitt
Chief Commercial Officer |
0 | 4,500 | 0 $0 | 1 |
Feb 10, 2023
Reduced 100.0%
|
Sessa Capital (Master), L.P.
> 10% Shareholder |
8,879,023 | 24,403,628 | 0 $0 | 8 |
Apr 27, 2023
Reduced 100.0%
|